Latest News

January 12, 2024

E4112 study shows a gene expression assay may guide ductal carcinoma in-situ management

January 11, 2024

Tempus announces participation in ComboMATCH

January 10, 2024

46 member networks and programs receive commendations for research performance

January 9, 2024

Dr. Etta Pisano, chair of the TMIST trial, talks with CBS Health Watch about artificial intelligence (AI) for breast cancer screening

January 8, 2024

Monica Bertagnolli’s priorities as NIH director include broadening participation in medical research

January 5, 2024

The new NCI precision medicine trials: ComboMATCH, iMATCH, and myeloMATCH

January 2, 2024

A variety of treatment options are becoming available in metastatic colorectal cancer: An overview with Kristen Ciombor, MD (includes mention of EA2201)

January 2, 2024

Inaugural episode of Aunt Minnie podcast features ECOG-ACRIN Group Co-Chair Dr. Mitch Schnall: Why should medical students choose radiology?

December 31, 2023

Dr. Kristin Ciombor discusses treatment options becoming available in colorectal cancer, including EA2201


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1300 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
41

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group